BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6805257)

  • 1. Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenström's macroglobulinemia.
    Fine JM; Lambin P; Massari M; Leroux P
    Acta Med Scand; 1982 May; 211(3):237-9. PubMed ID: 6805257
    [No Abstract]   [Full Text] [Related]  

  • 2. Waldenström's macroglobulinemia in monozygotic twins.
    Fine JM; Muller JY; Rochu D; Marneux M; Gorin NC; Fine A; Lambin P
    Acta Med Scand; 1986; 220(4):369-73. PubMed ID: 3099545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
    Mailankody S; Landgren O
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM-expressing Waldenstrom's macroglobulinemia tumor cells reveal a potential for isotype switch events in vivo.
    Babbage G; Townsend M; Zojer N; Mockridge IC; Garand R; Barlogie B; Shaughnessy J; Stevenson FK; Sahota SS
    Leukemia; 2007 Apr; 21(4):827-30. PubMed ID: 17287856
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
    Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroglobulinaemia in an Icelandic family.
    Björnsson OG; Arnason A; Gudmunosson S; Jensson O; Olafsson S; Valimarsson H
    Acta Med Scand; 1978; 203(4):283-8. PubMed ID: 417561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
    Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
    Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four brothers with Waldenstrom's macroglobulinemia.
    Renier G; Ifrah N; Chevailler A; Saint-Andre JP; Boasson M; Hurez D
    Cancer; 1989 Oct; 64(7):1554-9. PubMed ID: 2505923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The malignant clone in Waldenstrom's macroglobulinemia.
    Kriangkum J; Taylor BJ; Mant MJ; Treon SP; Belch AR; Pilarski LM
    Semin Oncol; 2003 Apr; 30(2):132-5. PubMed ID: 12720122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression.
    Konduri K; Sahota SS; Babbage G; Tong AW; Kumar P; Newman JT; Stone MJ
    Clin Lymphoma; 2005 Mar; 5(4):285-9. PubMed ID: 15794867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-smooth-muscle antibody activity of monoclonal IgM in Waldenström's disease].
    Krulik M; Vittecoq D; Abuaf N; Genot JY; Homberg JC; Debray J
    Sem Hop; 1983 Jun; 59(23):1737-41. PubMed ID: 6308799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Waldenström's macroglobulinemia].
    Arderiu Freixa A; Ordi Ros J; Mirada Canals A
    Rev Clin Esp; 1981 Nov; 163(3):151-6. PubMed ID: 6799992
    [No Abstract]   [Full Text] [Related]  

  • 14. Waldenström's macroglobulinemia and myasthenia gravis.
    Bartoloni C; Scoppetta C; Flamini G; Guidi L; Bartoccioni E; Lambiase M; Gambassi G; Terranova T
    J Clin Lab Immunol; 1981 Nov; 6(3):275-8. PubMed ID: 6802976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Waldenstrom's macroglobulinemia.
    McMaster ML
    Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular skin lesion and monoclonal lymphoplasmacytoid infiltrates. Occurrence in primary Waldenström's macroglobulinemia.
    Mozzanica N; Finzi AF; Facchetti G; Villa ML
    Arch Dermatol; 1984 Jun; 120(6):778-81. PubMed ID: 6426407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two M-components in a single cell lineage in a patient with a dual isotype secretory B-cell tumour.
    Sakashita C; Saito T; Kurosu T; Yoshinaga H; Kumagai T; Yamamoto K; Miki T; Koyama T; Miura O; Nemoto T; Asakawa H; Hirosawa S
    Br J Haematol; 1998 Aug; 102(3):791-4. PubMed ID: 9722308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
    Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
    Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.